PT Siloam International Hospitals Tbk (ISX:SILO) COGS-to-Revenue : 0.62 (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is PT Siloam International Hospitals Tbk COGS-to-Revenue?

PT Siloam International Hospitals Tbk's Cost of Goods Sold for the three months ended in Mar. 2024 was Rp1,871,589 Mil. Its Revenue for the three months ended in Mar. 2024 was Rp3,027,020 Mil.

PT Siloam International Hospitals Tbk's COGS to Revenue for the three months ended in Mar. 2024 was 0.62.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. PT Siloam International Hospitals Tbk's Gross Margin % for the three months ended in Mar. 2024 was 38.17%.

PT Siloam International Hospitals Tbk COGS-to-Revenue Historical Data

The historical data trend for PT Siloam International Hospitals Tbk's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Siloam International Hospitals Tbk COGS-to-Revenue Chart

PT Siloam International Hospitals Tbk Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.69

0.67

0.61

0.63

0.60

PT Siloam International Hospitals Tbk Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.62	0.62	0.59	0.58	0.62

PT Siloam International Hospitals Tbk COGS-to-Revenue Calculation

PT Siloam International Hospitals Tbk's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	6735289	/	11190511
	=	0.60

PT Siloam International Hospitals Tbk's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1871589	/	3027020
	=	0.62

PT Siloam International Hospitals Tbk (ISX:SILO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

PT Siloam International Hospitals Tbk's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1871589 / 3027020
	=	38.17 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

PT Siloam International Hospitals Tbk COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of PT Siloam International Hospitals Tbk's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Siloam International Hospitals Tbk (ISX:SILO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PT Siloam International Hospitals Tbk (ISX:SILO) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

2LS:Germany

Address

Jl. Boulevard Jend.Sudirman No. 15 Lippo Village, Fakultas Kedokteran Universitas Pelita Harapan, Lantai 32, Banten, Tangerang, IDN, 15810

Website

https://www.siloamhospitals.com

PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. The company manages and operates multiple hospitals in Jadebotabek. Siloam Hospitals makes investments in both technology and medical staff to offer a range of medical services. The company also manages Centers of Excellence that address medical cases requiring complex treatment. The company derives its revenue from inpatient and outpatient services. Inpatient services derive revenue from medical support and medical specialist services, drugs and medical supplies, and inpatient rooms. Outpatient services derive revenue from the delivery of medical support and medical specialist services; drugs and medical supplies; hospital facilities. Inpatient services are responsible for a majority of company revenue.